University Medical Center Maribor, Department of Cardiology and Angiology, Ljubljanska ulica 5, 2000 Maribor, Slovenia.
Eur J Intern Med. 2019 Aug;66:81-84. doi: 10.1016/j.ejim.2019.06.004. Epub 2019 Jun 11.
Mortality after myocardial infarction is higher in women than in men. Data on the association between sex and mortality are conflicting and inconclusive. We evaluated whether there is a sex difference in survival and if sex is associated with the outcome in patients with ST-elevation myocardial infarction (STEMI).
We analyzed 3671 STEMI patients. Long-term and 30-day mortality in men and women were compared.
Unadjusted mortality at day 30 was higher in women [221 (8.7%) men died compared to 147 (13.1%) women; p < 0.0001]. After multivariate adjustments, this became insignificant (OR 1.65; 95% CI; 0.81 to 1.40). The long-term, unadjusted mortality was also higher in women [674 (26.3%) men died compared to 382 (34%) women; p < 0.0001]. After multivariable adjustments, female sex (adjusted HR 0.81; 95% CI 0.71 to 0.93; p = 0.002), bleeding (adjusted HR 1.79; 95% CI 1.52 to 2.10; p < 0.0001), renal dysfunction adjusted HR (1.60; 95% CI 1.40 to 1.84; p < 0.0001), hyperlipidemia (adjusted HR 1.61; 95% CI 1.40 to 1.85; p < 0.0001), arterial hypertension (adjusted HR 1.17; 95% CI 1.03 to 1.33; p = 0.015), diabetes (adjusted HR 1.55; 95% CI 1.35 to 1.78; p < 0.0001), age (adjusted HR 1.05; 95% CI 1.04 to 1.06; p < 0.0001), anemia on admission (adjusted HR 1.38; 95% CI 1.23 to 1.58; p < 0.0001), and heart failure (adjusted HR 2.40; 95% CI 2.09 to 2.75; p < 0.0001) predicted long-term mortality.
Female sex was associated with a lower risk of dying in the long term. However, risk factors, age, and comorbidities associated with female patients affected the worse outcome.
心肌梗死后女性的死亡率高于男性。关于性别与死亡率之间的关系的数据存在争议且尚无定论。我们评估了在 ST 段抬高型心肌梗死(STEMI)患者中是否存在性别与生存率之间的差异,以及性别是否与结局相关。
我们分析了 3671 例 STEMI 患者。比较了男性和女性的 30 天和长期死亡率。
未经调整的 30 天死亡率女性更高[221(8.7%)名男性死亡,相比之下,女性为 147(13.1%)名;p<0.0001]。经过多变量调整后,这变得无统计学意义(OR 1.65;95%CI;0.81 至 1.40)。未经调整的长期死亡率女性也更高[674(26.3%)名男性死亡,相比之下,女性为 382(34%)名;p<0.0001]。经过多变量调整后,女性性别(调整后的 HR 0.81;95%CI 0.71 至 0.93;p=0.002)、出血(调整后的 HR 1.79;95%CI 1.52 至 2.10;p<0.0001)、肾功能障碍调整后的 HR(1.60;95%CI 1.40 至 1.84;p<0.0001)、血脂异常(调整后的 HR 1.61;95%CI 1.40 至 1.85;p<0.0001)、高血压(调整后的 HR 1.17;95%CI 1.03 至 1.33;p=0.015)、糖尿病(调整后的 HR 1.55;95%CI 1.35 至 1.78;p<0.0001)、年龄(调整后的 HR 1.05;95%CI 1.04 至 1.06;p<0.0001)、入院时贫血(调整后的 HR 1.38;95%CI 1.23 至 1.58;p<0.0001)和心力衰竭(调整后的 HR 2.40;95%CI 2.09 至 2.75;p<0.0001)预测了长期死亡率。
女性性别与长期死亡风险降低相关。然而,与女性患者相关的风险因素、年龄和合并症影响了结局。